May 12, 2024

Visionary Group Has World-Class Biochip Technology Products That Have Made Significant Contributions To The Commercial And Social Aspects Of Global Medical/Health/New Agricultural Innovation Technologies. Visionary Group is a NASDAQ-listed company in the United States that cooperated with Canada’s B. Braun Biochip Technology Group to establish Visionary Biotechnology Group Co., Ltd. in Toronto. Both economic value and social value will have an important impact. Visionary Group has a global impact in the field of biotechnology. Important value for short, medium and long term investors. CEDB Frank Chen 2024.May 12 Visionary Group has world-class biochip technology products to fill the vast market gap in Canada. B. Braun was founded in March 2011 at UBC University in Vancouver, Canada by Victor C.M. Leung, an academician of the Royal Canadian Academy of Sciences and the Academy of Engineering, and other Canadian academicians and American academician professors. B. Braun has invested nearly 150 million US dollars. After more than 10 years of focusing on the development of biochips, it has cooperated with the United States , and famous Canadian medical institutions have cooperated to develop a variety of products for medical bed testing, drug research and development, animal quarantine and cold chain transportation, including medical chips, animal chips, cold chain chips and agricultural chips. Currently, the products have Complete clinical testing, process technology verification and small-scale production.   The ability to realize applications in clinical testing, process validation and small-scale production demonstrates B. Braun’s advantages and progress in this technical field. In addition, B. Braun cooperated with Ruikun Technology Group to build a factory in Nantong, China, with a total investment of US$300 million. This investment will not only help fill China’s technological gaps in this field, but is also expected to bring up to 30 million US dollars in the next five years. The output value of more than 100 million US dollars will have an important impact on the economic value and social value of the B. Braun Group.   Visionary Group has cooperated with China’s Zhejiang Ruikun Technology Group to build a factory in Nantong, China with a total investment of US$300 million to fill the gap in China’s vast market. It is planned to be put into production in March 2025, with an output value of more than 3 billion US dollars in the next five years, creating huge economic and social value for the Vision Group.   Innovative biochip technology demonstrates the company’s world-class achievements in the field of biotechnology. Through long-term dedicated research and development of biochip technology and cooperation with famous medical institutions in North America, the company has successfully developed a variety of products that are used in many fields such as medical treatment, drug research and development, animal quarantine, and cold chain transportation.   Vision Biotechnology Group Co., Ltd.’s innovative biochip technology demonstrates the company’s world-class achievements in the field of biotechnology. Through long-term dedicated research and development of biochip technology, the company has successfully developed a variety of products that are used in medical treatment, drug research and development, animal quarantine and cold chain transportation due to cooperation with medical institutions of the famous Canadian B. Braun Biochip Technology Group in North America. and many other fields.   Medical chips, animal chips, cold chain chips and agricultural chip products can be used in clinical testing, process verification and small-scale production, showing that Vision Biotechnology Group Co., Ltd.’s B. Braun Biochip Technology is the Top 1 market in this technology field. Advantage. In addition, B. Braun Biochip Technology has cooperated with Ruikun Technology Group to build a factory in Nantong, China, with a total investment of US$300 million. This investment will not only help fill China’s technology gap in this field, but is also expected to bring about with an output value of more than 3 billion US dollars, it will have an important impact on both the economic value and social value of Vision Biotechnology Group Co., Ltd.   1. Medical chip, animal chip, cold chain chip and agricultural chip technology innovation: The cooperation between Vision Group and B. Braun’s biochip technology company represents the combination of global high-end manufacturing and biotechnology, which brings innovative solutions to key industries such as medical care. plan.   2. Leading the biochip market: Top 1 medical chips, animal chips, cold chain chips and agricultural chips fill the gaps in the Canadian and Chinese markets. B. Braun holds a leading position in the global biochip market.   3. Cooperation and expansion: Vision Group’s cooperation with internationally renowned institutions and the expansion of its global production base show its high growth potential and influence.   4. Global social contribution: Providing high-precision biochip products helps improve the health and welfare of humans and animals around the world.   5. High economic value: The expected output value of more than 3 billion US dollars in the next five years shows its huge market potential and economic benefits.   Vision Group and B. Braun Group jointly established Vision Biotechnology Group Co., Ltd., which is moving towards becoming an important force in the global biochip industry and making significant contributions to global medical/health/new agricultural innovation technologies in all aspects of business and society. Biochips Market Size And Industry Analysis   The global Biochips Market Size was valued at $12,005 million in 2021 and is projected to reach $25,568 million in 2028. The market is likely to grow with a high CAGR of 11.3% during the forecast period. The report presents comprehensive projections on the growth factors, opportunities, and restraining factors. It also covers the geographical market along with comprehensive competitive landscape analysis.   Biochip Market: Overview   Biochip is a biosecurity miniaturized medical device which helps in tracking accurate information. Additionally, it is massively used in molecular biology. These chips are capable of undergoing thousands of biological reactions in less time.   COVID-19 Impact   The outbreak of the Covid-19 pandemic is likely to positively impact the growth of the global biochip market. Its growing applications align with the innovation of the Covid-19 vaccines and drugs, which in

Visionary Group is Canada’s first independent brand of new energy vehicles in the field of new energy vehicles. It is driven by innovation, has a global vision, professional cooperation and attaches great importance to sustainable development, providing multiple short, medium and long-term investment advantages. Visionary Group Of U.S. Nasdaq listed company is Canada’s first independent brand of new energy vehicles in the field of new energy vehicles. It is driven by innovation, has a global vision, professional cooperation and attaches great importance to sustainable development, providing multiple short, medium and long-term investment advantages. CEDB Frank Chen 2024 05 12 Visionary Group (Visionary) is embracing an inclusive new business operation method, using the “global trend path of professional mergers and acquisitions to integrate high innovative value” as the best global business model, joining hands with global elites, and leading the operation with high innovation and excellence. Development and growth.   In the field of new energy vehicles, Yuanyan reached an agreement with Fano Holding Group and the two parties cooperated to build a factory in Toronto, becoming Canada’s first independent brand of new energy vehicles and filling a gap in Canada. Products include sports cars, mini cars, cold chain/logistics vehicles, electric buses and yachts and other series of new energy vehicles. Fano has a large number of world-leading special technologies in the field of electric and hybrid vehicles. At the same time, the company is headed by Giorgio Stirano, a well-known Italian racing engineer. President and Technical Director, with bright future prospects.   Visionary and Fano Holding Group established a new energy vehicle factory in Toronto, Canada, marking the in-depth cooperation between the two parties and demonstrating their emphasis on the new energy vehicle market. It has created core market value and market investment value advantages:   1. Innovation-driven: Through cooperation with Fano Holding Group, which possesses cutting-edge technology, it shows that Visionary Group focuses on the application and development of innovative technologies, which is the key to promoting the company’s growth in the field of new energy vehicles.   2. Global Vision: Visionary Group’s actions indicate that it pursues global markets, collaborates with multinational talents and builds business on the international stage, which shows its vision to embrace global trends.   3. Professional cooperation: Visionary chooses to cooperate with partners with professional skills and technology, such as the joining of Italian racing engineer Giorgio Stirano, which highlights the importance of the company’s emphasis on professional knowledge and technical expertise in operations.   4. Leadership and performance: Visionary Group emphasizes excellent leadership and operational effectiveness, which demonstrates its commitment to driving the company’s growth and success through a strong management team.   5. Sustainable development: Focusing on the development of the new energy vehicle industry shows that Visionary Group pays attention to sustainability and environmental protection, which is a core part of its long-term development strategy. strategy. Advantages of market investment value   1. Innovative first-mover advantage: As Canada’s first independent brand new energy vehicle manufacturer, this company may enjoy a first-mover advantage in the market. This means it can build brand recognition before competitors, establish a customer base, and influence market standards.   2. Strong support from Canadian government policies: New energy vehicles have received support from governments of many countries, including subsidies, tax breaks and other measures. The Canadian government may provide various incentives to promote the development of the local new energy vehicle industry, which may be a major advantage for the cooperation project between Vision and Fano.   3. ESG environmental protection trends: As the world pays increasing attention to carbon reduction and climate change issues, the demand for new energy vehicles is expected to grow rapidly. The establishment of this cooperative factory is expected to capture the long-term investment value brought by this market trend.   4. High technology and innovation: The new energy automobile industry is in a stage of rapid development, and technological innovation is an important driving force for the industry. If the cooperation between Yuanyuan and Fano can achieve breakthroughs in battery technology, electric drive systems and other fields, it may enhance its competitiveness.   5. Potential for international cooperation: With the establishment of Canadian local brands, there may be more international cooperation opportunities in the future, such as export business expansion and cross-border technical cooperation.   6. Financing and investment attractiveness: A high-tech project with potential, especially in the clean energy sector, can usually attract investors and government funding. The partnership is likely to benefit from a positive reaction from capital markets.   These values are reflected in the company’s business operations and strategies, proving the promise of the Vision Group name – a forward-looking and visionary enterprise. Vision Group’s new energy vehicle products cover a wide range of products and are an important reflection of its global market advantages. Global market advantages:    1. Diversified product lines: Having a diversified product portfolio from sports cars to electric buses can meet the needs and preferences of different market segments, helping the Vision Group to reduce any single market risk.   2. Innovation Pioneer: As an innovator in the field of new energy vehicles, Visionary Group can establish a leading position in emerging markets and become a reliable green transportation solution provider in developed markets.   3. Wide coverage: From luxury sports cars to daily commuter vehicles, to professional cold chain/logistics transportation and public transportation systems, this product range enables Visionary to reach a wide range of customer groups.   4. Comply with sustainable development goals: As the world pays more and more attention to sustainable development, Visionary Group’s new energy vehicles are in line with this trend and are an attraction for consumers and businesses pursuing green energy and reducing carbon footprints. s Choice.   5. Respond to regulatory changes: As countries around the world gradually strengthen legal restrictions on traditional fuel vehicles, providing a full range of new energy models can help the Vision Group better adapt to these changes and thereby gain competitive advantages in different markets.   6. Accumulation of technology and experience: In the field of new energy, the accumulation of manufacturing technology